Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ting Shu

Showing results (291-300 of 330) with videos related to

Pageof 33
Sort By:
Journal of Gastroenterology and Hepatology|December 10, 2016
Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver diseaseThomson Chi-Wang Loong, Jeremy Lok Wei, Jonathan Chung-Fai Leung, et al.
Gut Microbes|June 11, 2024
Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung diseaseTzu-Lung Lin, Yen-Liang Kuo, Juo-Hsin Lai, et al.
Ebiomedicine|July 26, 2024
Blood pressure response index and clinical outcomes in patients with septic shock: a multicenter cohort studyYujie Chen, Huizhen Jiang, Yuna Wei, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2019
Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver diseaseSarah Shili-Masmoudi, Grace Lai-Hung Wong, Jean-Baptiste Hiriart, et al.
Gut|April 16, 2015
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort studyRaymond Kwok, Kai Chow Choi, Grace Lai-Hung Wong, et al.
Infectious Diseases and Therapy|July 21, 2022
Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli BacteremiaShang-Yi Lin, Po-Liang Lu, Ting-Shu Wu, et al.
Jac-Antimicrobial Resistance|May 13, 2026
Clinical implications of cefoperazone-sulbactam MIC values in <i>Pseudomonas aeruginosa</i> bloodstream infections: a multicentre studyShian-Sen Shie, Ting-Shu Wu, Feng-Yee Chang, et al.
Chinese Medical Journal|March 19, 2026
Validation and modification of the phoenix sepsis score for predicting in-hospital mortality in children with suspected infection admitted to the intensive care unitYehan Qiu, Dong Qu, Shaobo Wang, et al.
Immunobiology|October 23, 2012
Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseasesWen-I Lee, Jing-Long Huang, Ting-Shu Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 2, 2020
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the DiseaseVincent Wai-Sun Wong, Grace Lai-Hung Wong, Jean Woo, et al.
Pageof 33

Showing results (291-300 of 330) with videos related to

Sort By:
Pageof 33
Journal of Gastroenterology and Hepatology|December 10, 2016
Application of the combined FibroMeter vibration-controlled transient elastography algorithm in Chinese patients with non-alcoholic fatty liver diseaseThomson Chi-Wang Loong, Jeremy Lok Wei, Jonathan Chung-Fai Leung, et al.
Gut Microbes|June 11, 2024
Gut microbiota dysbiosis-related susceptibility to nontuberculous mycobacterial lung diseaseTzu-Lung Lin, Yen-Liang Kuo, Juo-Hsin Lai, et al.
Ebiomedicine|July 26, 2024
Blood pressure response index and clinical outcomes in patients with septic shock: a multicenter cohort studyYujie Chen, Huizhen Jiang, Yuna Wei, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 22, 2019
Liver stiffness measurement predicts long-term survival and complications in non-alcoholic fatty liver diseaseSarah Shili-Masmoudi, Grace Lai-Hung Wong, Jean-Baptiste Hiriart, et al.
Gut|April 16, 2015
Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort studyRaymond Kwok, Kai Chow Choi, Grace Lai-Hung Wong, et al.
Infectious Diseases and Therapy|July 21, 2022
Correlation Between Cefoperazone/Sulbactam MIC Values and Clinical Outcomes of Escherichia coli BacteremiaShang-Yi Lin, Po-Liang Lu, Ting-Shu Wu, et al.
Jac-Antimicrobial Resistance|May 13, 2026
Clinical implications of cefoperazone-sulbactam MIC values in <i>Pseudomonas aeruginosa</i> bloodstream infections: a multicentre studyShian-Sen Shie, Ting-Shu Wu, Feng-Yee Chang, et al.
Chinese Medical Journal|March 19, 2026
Validation and modification of the phoenix sepsis score for predicting in-hospital mortality in children with suspected infection admitted to the intensive care unitYehan Qiu, Dong Qu, Shaobo Wang, et al.
Immunobiology|October 23, 2012
Patients with inhibitory and neutralizing auto-antibodies to interferon-γ resemble the sporadic adult-onset phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) lacking Bacille Calmette-Guerin (BCG)-induced diseasesWen-I Lee, Jing-Long Huang, Ting-Shu Wu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 2, 2020
Impact of the New Definition of Metabolic Associated Fatty Liver Disease on the Epidemiology of the DiseaseVincent Wai-Sun Wong, Grace Lai-Hung Wong, Jean Woo, et al.
Pageof 33